On the Use of Hyperpolarized Helium MRI for Conformal Avoidance Lung Radiotherapy

C. W. Hodge, Wolfgang A. Tome, S. B. Fain, S. M. Bentzen, M. P. Mehta

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We wanted to illustrate the feasibility of using hyperpolarized helium magnetic resonance imaging (HPH-MRI) to obtain functional information that may assist in improving conformal avoidance of ventilating lung tissue during thoracic radiotherapy. HPH-MRI images were obtained from a volunteer patient and were first fused with a proton density-weighted (PDw) MRI to provide corresponding anatomic detail; they were then fused with the treatment planning computed tomography scan of a patient from our treatment planning database who possessed equivalent thoracic dimensions. An optimized treatment plan was then generated using the TomoTherapy treatment planning system, designating the HPH-enhancing regions as ventilation volume (VV). A dose-volume histogram compares the dosimetry of the lungs as a paired organ, the VV, and the lungs minus the VV. The clinical consequences of these changes was estimated using a bio-effect model, the parallel architecture model, or the local damage (fdam) model. Model parameters were chosen from published studies linking the incidence of grade 3+ pneumonitis, with the dose and volume irradiated. For two hypothetical treatment plans of 60 Gy in 30 fractions delivered to a right upper-lobe lung mass, one using and one ignoring the VV as an avoidance structure, the mean normalized total dose (NTDmean) values for the lung subvolumes were: lungs = 12.5 Gy3 vs. 13.52 Gy3, VV = 9.94 Gy3 vs. 13.95 Gy3, and lungs minus VV = 16.69 Gy3 vs. 19.16 Gy3. Using the fdam values generated from these plans, one would predict a reduction of the incidence of grade 3+ radiation pneumonitis from 12%-4% when compared with a conventionally optimized plan. The use of HPH-MRI to identify ventilated lung subvolumes is feasible and has the potential to be incorporated into conformal avoidance treatment planning paradigms. A prospective clinical study evaluating this imaging technique is being developed.

Original languageEnglish (US)
Pages (from-to)297-303
Number of pages7
JournalMedical Dosimetry
Volume35
Issue number4
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Helium
Radiotherapy
Ventilation
Lung
Magnetic Resonance Imaging
Thorax
Therapeutics
Radiation Pneumonitis
Organ Size
Protons
Volunteers
Pneumonia
Cohort Studies
Tomography
Databases
Prospective Studies
Incidence

Keywords

  • Functional imaging
  • Image guidance
  • Lung cancer
  • Magnetic resonance imaging
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

On the Use of Hyperpolarized Helium MRI for Conformal Avoidance Lung Radiotherapy. / Hodge, C. W.; Tome, Wolfgang A.; Fain, S. B.; Bentzen, S. M.; Mehta, M. P.

In: Medical Dosimetry, Vol. 35, No. 4, 2010, p. 297-303.

Research output: Contribution to journalArticle

Hodge, C. W. ; Tome, Wolfgang A. ; Fain, S. B. ; Bentzen, S. M. ; Mehta, M. P. / On the Use of Hyperpolarized Helium MRI for Conformal Avoidance Lung Radiotherapy. In: Medical Dosimetry. 2010 ; Vol. 35, No. 4. pp. 297-303.
@article{877fce923f7e477c9e47ba56b31a663f,
title = "On the Use of Hyperpolarized Helium MRI for Conformal Avoidance Lung Radiotherapy",
abstract = "We wanted to illustrate the feasibility of using hyperpolarized helium magnetic resonance imaging (HPH-MRI) to obtain functional information that may assist in improving conformal avoidance of ventilating lung tissue during thoracic radiotherapy. HPH-MRI images were obtained from a volunteer patient and were first fused with a proton density-weighted (PDw) MRI to provide corresponding anatomic detail; they were then fused with the treatment planning computed tomography scan of a patient from our treatment planning database who possessed equivalent thoracic dimensions. An optimized treatment plan was then generated using the TomoTherapy treatment planning system, designating the HPH-enhancing regions as ventilation volume (VV). A dose-volume histogram compares the dosimetry of the lungs as a paired organ, the VV, and the lungs minus the VV. The clinical consequences of these changes was estimated using a bio-effect model, the parallel architecture model, or the local damage (fdam) model. Model parameters were chosen from published studies linking the incidence of grade 3+ pneumonitis, with the dose and volume irradiated. For two hypothetical treatment plans of 60 Gy in 30 fractions delivered to a right upper-lobe lung mass, one using and one ignoring the VV as an avoidance structure, the mean normalized total dose (NTDmean) values for the lung subvolumes were: lungs = 12.5 Gy3 vs. 13.52 Gy3, VV = 9.94 Gy3 vs. 13.95 Gy3, and lungs minus VV = 16.69 Gy3 vs. 19.16 Gy3. Using the fdam values generated from these plans, one would predict a reduction of the incidence of grade 3+ radiation pneumonitis from 12{\%}-4{\%} when compared with a conventionally optimized plan. The use of HPH-MRI to identify ventilated lung subvolumes is feasible and has the potential to be incorporated into conformal avoidance treatment planning paradigms. A prospective clinical study evaluating this imaging technique is being developed.",
keywords = "Functional imaging, Image guidance, Lung cancer, Magnetic resonance imaging, Radiotherapy",
author = "Hodge, {C. W.} and Tome, {Wolfgang A.} and Fain, {S. B.} and Bentzen, {S. M.} and Mehta, {M. P.}",
year = "2010",
doi = "10.1016/j.meddos.2009.09.004",
language = "English (US)",
volume = "35",
pages = "297--303",
journal = "Medical Dosimetry",
issn = "0958-3947",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - On the Use of Hyperpolarized Helium MRI for Conformal Avoidance Lung Radiotherapy

AU - Hodge, C. W.

AU - Tome, Wolfgang A.

AU - Fain, S. B.

AU - Bentzen, S. M.

AU - Mehta, M. P.

PY - 2010

Y1 - 2010

N2 - We wanted to illustrate the feasibility of using hyperpolarized helium magnetic resonance imaging (HPH-MRI) to obtain functional information that may assist in improving conformal avoidance of ventilating lung tissue during thoracic radiotherapy. HPH-MRI images were obtained from a volunteer patient and were first fused with a proton density-weighted (PDw) MRI to provide corresponding anatomic detail; they were then fused with the treatment planning computed tomography scan of a patient from our treatment planning database who possessed equivalent thoracic dimensions. An optimized treatment plan was then generated using the TomoTherapy treatment planning system, designating the HPH-enhancing regions as ventilation volume (VV). A dose-volume histogram compares the dosimetry of the lungs as a paired organ, the VV, and the lungs minus the VV. The clinical consequences of these changes was estimated using a bio-effect model, the parallel architecture model, or the local damage (fdam) model. Model parameters were chosen from published studies linking the incidence of grade 3+ pneumonitis, with the dose and volume irradiated. For two hypothetical treatment plans of 60 Gy in 30 fractions delivered to a right upper-lobe lung mass, one using and one ignoring the VV as an avoidance structure, the mean normalized total dose (NTDmean) values for the lung subvolumes were: lungs = 12.5 Gy3 vs. 13.52 Gy3, VV = 9.94 Gy3 vs. 13.95 Gy3, and lungs minus VV = 16.69 Gy3 vs. 19.16 Gy3. Using the fdam values generated from these plans, one would predict a reduction of the incidence of grade 3+ radiation pneumonitis from 12%-4% when compared with a conventionally optimized plan. The use of HPH-MRI to identify ventilated lung subvolumes is feasible and has the potential to be incorporated into conformal avoidance treatment planning paradigms. A prospective clinical study evaluating this imaging technique is being developed.

AB - We wanted to illustrate the feasibility of using hyperpolarized helium magnetic resonance imaging (HPH-MRI) to obtain functional information that may assist in improving conformal avoidance of ventilating lung tissue during thoracic radiotherapy. HPH-MRI images were obtained from a volunteer patient and were first fused with a proton density-weighted (PDw) MRI to provide corresponding anatomic detail; they were then fused with the treatment planning computed tomography scan of a patient from our treatment planning database who possessed equivalent thoracic dimensions. An optimized treatment plan was then generated using the TomoTherapy treatment planning system, designating the HPH-enhancing regions as ventilation volume (VV). A dose-volume histogram compares the dosimetry of the lungs as a paired organ, the VV, and the lungs minus the VV. The clinical consequences of these changes was estimated using a bio-effect model, the parallel architecture model, or the local damage (fdam) model. Model parameters were chosen from published studies linking the incidence of grade 3+ pneumonitis, with the dose and volume irradiated. For two hypothetical treatment plans of 60 Gy in 30 fractions delivered to a right upper-lobe lung mass, one using and one ignoring the VV as an avoidance structure, the mean normalized total dose (NTDmean) values for the lung subvolumes were: lungs = 12.5 Gy3 vs. 13.52 Gy3, VV = 9.94 Gy3 vs. 13.95 Gy3, and lungs minus VV = 16.69 Gy3 vs. 19.16 Gy3. Using the fdam values generated from these plans, one would predict a reduction of the incidence of grade 3+ radiation pneumonitis from 12%-4% when compared with a conventionally optimized plan. The use of HPH-MRI to identify ventilated lung subvolumes is feasible and has the potential to be incorporated into conformal avoidance treatment planning paradigms. A prospective clinical study evaluating this imaging technique is being developed.

KW - Functional imaging

KW - Image guidance

KW - Lung cancer

KW - Magnetic resonance imaging

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=78049473840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049473840&partnerID=8YFLogxK

U2 - 10.1016/j.meddos.2009.09.004

DO - 10.1016/j.meddos.2009.09.004

M3 - Article

VL - 35

SP - 297

EP - 303

JO - Medical Dosimetry

JF - Medical Dosimetry

SN - 0958-3947

IS - 4

ER -